top
Search terms
Results 1 - 10 of 137 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 14
Ehjcvp

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of ...

European Heart Journal - Cardiovascular Pharmacotherapy, Corrigendum

Date : 14/07/2016 Item size : 90286 bytes
Ehjcvp

The Systolic Blood Pressure Intervention Trial (SPRINT) enrolled 9300 participants age 50 years and older without diabetes or previous stroke in 100 expert medical centres and clinical practices ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Sverre E. Kjeldsen, Giuseppe Mancia

Date : 01/04/2016 Item size : 128053 bytes
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjcvp

In this issue of European Heart Journal: Cardiovascular Pharmacology, Johnson et al. report an observational study on the relationship between conventional risk factors and the incidence of AF in ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Farhan Shahid, Eduard Shantsila, Gregory Y. H. Lip

Date : 01/04/2016 Item size : 149125 bytes
Ehjcvp

Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events Introduction Cardiovascular disease (CVD) is widespread, ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Laura A. Fortuna, Pamala A. Pawloski, Emily D. Parker, Nicole K. Trower, Thomas E. Kottke

Date : 01/01/2016 Item size : 263457 bytes
Ehjcvp

Dear Editor, as explained in the review article on SGLT2 inhibition by de Leeuw et al.,1 SGLT2 is a low-affinity high-capacity cotransporter, expressed proximally in the tubular system (see ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Francisco Javier Martinez-Martin, Natalia Jimenez-Martin, Nery Sablon-Gonzalez

Date : 30/05/2016 Item size : 108816 bytes
Ehjcvp

Abstract Aims An important decision in the management of patients with atrial fibrillation is whether to adopt a rate or rhythm control strategy. Methods and results We conducted a retrospective ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Carl Hayward, Hitesh C. Patel, Ketna Patel, Carlo Di Mario, Alexander R. Lyon, Syed Y. Ahsan, Edward Rowland

Date : 01/04/2016 Item size : 222623 bytes
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Ehjcvp

[...]of progress made in HFREF therapy, cumulative mortality benefit amounts to almost a three-fold decrease in death rate whether in severe or in mild-to-moderate HFREF. In chronic HEFREF, it is ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Faiez Zannad

Date : 01/01/2015 Item size : 180641 bytes
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes